Shuttle Pharmaceuticals Holdings (SHPH) Assets Average (2022 - 2026)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Assets Average came in at $11.1 million in Q1 2026, up 185.11% year-on-year from $3.9 million in Q1 2025, and up 58.97% quarter-over-quarter from $7.0 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Assets Average (2022 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Assets Average history runs 5 years deep, the most recent figure standing at $11.1 million for Q1 2026.
- On a quarterly basis, Assets Average rose 185.11% year-over-year to $11.1 million in Q1 2026; TTM through Mar 2026 was $11.1 million, a 185.11% increase from a year earlier, with the FY2025 full-year figure at $6.5 million, up 53.49% from the prior year.
- Assets Average grew to $11.1 million in Q1 2026 per SHPH's latest filing, from $7.0 million in the prior quarter.
- Across five years, Assets Average topped out at $11.1 million in Q1 2026 and bottomed at $1.6 million in Q4 2024.
- The 5-year median for Assets Average is $6.0 million (2023), against an average of $6.2 million.
- Across the five-year window, Assets Average plunged 78.5% in 2024 and jumped 340.87% in 2025, its largest moves.
- Year by year, Assets Average stood at $9.0 million in 2022, then fell by 26.1% to $6.7 million in 2023, then plunged by 76.14% to $1.6 million in 2024, then jumped by 340.87% to $7.0 million in 2025, then jumped by 58.97% to $11.1 million in 2026.
- Per Business Quant, the three latest SHPH Assets Average figures stand at $11.1 million (Q1 2026), $7.0 million (Q4 2025), and $4.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - | 11.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.14 Mn |
| Dec 31, 2025 | 7.01 Mn |
| Sep 30, 2025 | 4.52 Mn |
| Jun 30, 2025 | 5.41 Mn |
| Mar 31, 2025 | 3.91 Mn |
| Dec 31, 2024 | 1.59 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Jun 30, 2024 | 3.78 Mn |
| Mar 31, 2024 | 5.35 Mn |
| Dec 31, 2023 | 6.66 Mn |
| Sep 30, 2023 | 8.11 Mn |
| Jun 30, 2023 | 9.64 Mn |
| Mar 31, 2023 | 9.55 Mn |
| Dec 31, 2022 | 9.02 Mn |